Editorial & Opinion
Dr. Gottlieb et al reply.
العنوان: | Dr. Gottlieb et al reply. |
---|---|
المؤلفون: | Gottlieb C; Chloe Gottlieb, MD, University of Ottawa Eye Institute and Department of Ophthalmology, Faculty of Medicine, University of Ottawa, and The Ottawa Hospital Research Institute, Ottawa, Ontario., Berard RA; Roberta A. Berard, MD, MSc, Division of Rheumatology, and Department of Pediatrics, Western University, London, Ontario., Levy DM; Deborah M. Levy, MD, MS, Division of Rheumatology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario., Fortin E; Eric Fortin, MD, University of Montreal Ophthalmology Clinical Center at Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada. |
المصدر: | The Journal of rheumatology [J Rheumatol] 2023 Jul 01. Date of Electronic Publication: 2023 Jul 01. |
Publication Model: | Ahead of Print |
نوع المنشور: | Letter |
اللغة: | English |
بيانات الدورية: | Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Toronto : Journal Of Rheumatology Publishing Co Original Publication: Toronto. |
مستخلص: | We thank the author for their reply 1 and appreciate the approach of having clear terminology and standard definitions within clinical practice guidelines or recommendations, that are applicable across specialist groups. A definition of controlled anterior uveitis or quiescent disease is important for treatment decisions, particularly when classifying a patient's disease as failing current therapy and making decisions for escalating therapy. |
تواريخ الأحداث: | Date Created: 20230703 Latest Revision: 20230703 |
رمز التحديث: | 20230704 |
DOI: | 10.3899/jrheum.2023-0509 |
PMID: | 37399460 |
قاعدة البيانات: | MEDLINE |
تدمد: | 0315-162X |
---|---|
DOI: | 10.3899/jrheum.2023-0509 |